COVID-19

Vaccine Development

Learn about efforts at Massachusetts General Hospital and beyond to develop vaccines for the SARS-CoV-2 virus (COVID-19).

Transmission electron micrograph of SARS-CoV-2 particles — Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

Multiple Vaccines May Be the Best Way to Stop COVID-19 Pandemic

The race to develop a vaccine for the SARS-CoV-2 virus is progressing at an unprecedented speed and scale, with approximately 135 vaccines now in development worldwide.

How A Mass General Vaccine Accelerator Could Play a Crucial Role

A unique platform developed in anticipation of a rapidly spreading infectious disease like COVID-19 is now being put into action to develop a vaccine.

Mass Eye and Ear and Mass General Advacing Gene-Based COVID-19 Vaccine

Officials announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2.

Support Mass General's Response to COVID-19

The Emergency Relief Fund supports comprehensive emergency care, critical research efforts and the dissemination of pertinent information.

COVID-19 Grand Rounds Series

The Department of Medicine presents a series of academic lectures on the impact of & response to the COVID-19 pandemic.

COVID-19 Advances in Motion

Information for health care professionals about the latest COVID-19 breakthroughs, research and clinical advances from Mass General.

Additional Resources on COVID-19 Vaccine Development:

Vaccines (COVID Explainer website co-authored by Mass General’s Galit Alter, PhD)
A Closer Look at the COVID-19 Vaccine Front Runners (Infectious Diseases Hub)
Coronavirus Vaccine Tracker (New York Times)

The Mass General Difference

Conditions & Treatments

Patients & Visitors

Research & Innovation

Coronavirus (COVID-19)